earnings
confidence high
sentiment positive
materiality 0.80
ResMed reports Q1 FY2022 revenue $904M (+20% YoY), diluted EPS $1.39, non-GAAP EPS $1.51
RESMED INC
2022-Q1 EPS reported
$1.39
revenue$904,015,000
- Revenue $904.0M, up 20% YoY (19% constant currency); all segments grew double-digits.
- Diluted EPS $1.39 (+14% YoY); non-GAAP diluted EPS $1.51 (+19% YoY).
- Income from operations $261.9M (+21%); non-GAAP operating profit $280.7M (+18%).
- Board declared quarterly cash dividend of $0.42/share, payable Dec 16, 2021, record Nov 11.
- CEO cited strong demand but ongoing supply chain constraints limiting electronic components.